Log in

Addus Homecare Stock Forecast, Price & News

+0.25 (+0.26 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $96.33
50-Day Range
MA: $94.64
52-Week Range
Now: $96.33
Volume324,800 shs
Average Volume138,701 shs
Market Capitalization$1.51 billion
P/E Ratio48.64
Dividend YieldN/A
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after surgery. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2018, the company served consumers through 156 offices located in 24 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Read More
Addus Homecare logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars

Industry, Sector and Symbol

Industry Home health care services
Current SymbolNASDAQ:ADUS



Sales & Book Value

Annual Sales$648.79 million
Cash Flow$2.45 per share
Book Value$30.57 per share


Net Income$25.24 million


Market Cap$1.51 billion
Next Earnings Date11/2/2020 (Estimated)
+0.25 (+0.26 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Addus Homecare (NASDAQ:ADUS) Frequently Asked Questions

How has Addus Homecare's stock been impacted by Coronavirus (COVID-19)?

Addus Homecare's stock was trading at $67.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ADUS stock has increased by 42.4% and is now trading at $96.33.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Addus Homecare?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Addus Homecare

When is Addus Homecare's next earnings date?

Addus Homecare is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Addus Homecare

How were Addus Homecare's earnings last quarter?

Addus Homecare Co. (NASDAQ:ADUS) posted its quarterly earnings results on Monday, August, 10th. The company reported $0.73 earnings per share for the quarter, beating analysts' consensus estimates of $0.44 by $0.29. The company had revenue of $184.58 million for the quarter, compared to the consensus estimate of $172.85 million. Addus Homecare had a return on equity of 8.38% and a net margin of 4.24%.
View Addus Homecare's earnings history

What price target have analysts set for ADUS?

6 Wall Street analysts have issued 1-year target prices for Addus Homecare's stock. Their forecasts range from $95.00 to $115.00. On average, they anticipate Addus Homecare's stock price to reach $105.00 in the next year. This suggests a possible upside of 9.0% from the stock's current price.
View analysts' price targets for Addus Homecare

Are investors shorting Addus Homecare?

Addus Homecare saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 224,900 shares, a drop of 45.8% from the August 15th total of 414,700 shares. Based on an average daily trading volume, of 110,600 shares, the short-interest ratio is currently 2.0 days.
View Addus Homecare's Short Interest

Who are some of Addus Homecare's key competitors?

What other stocks do shareholders of Addus Homecare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

Who are Addus Homecare's key executives?

Addus Homecare's management team includes the following people:
  • Mr. R. Dirk Allison, CEO, Pres & Director (Age 63)
  • Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 45)
  • Mr. W. Bradley Bickham, COO & Exec. VP (Age 56)
  • Mr. James Zoccoli, Exec. VP & Chief Information Officer (Age 62)
  • Mr. Darby Anderson, Exec. VP & Chief Devel. Officer (Age 53)

What is Addus Homecare's stock symbol?

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus Homecare's major shareholders?

Addus Homecare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (5.83%), TimesSquare Capital Management LLC (4.06%), Principal Financial Group Inc. (2.61%), Principal Financial Group Inc. (2.59%), FMR LLC (1.54%) and Emerald Advisers LLC (1.35%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus Homecare

Which major investors are selling Addus Homecare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, EAM Investors LLC, Driehaus Capital Management LLC, Marshall Wace North America L.P., Chartwell Investment Partners LLC, Fort Washington Investment Advisors Inc. OH, Sei Investments Co., and Axiom International Investors LLC DE. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver, and W Bradley Bickham.
View insider buying and selling activity for Addus Homecare

Which major investors are buying Addus Homecare stock?

ADUS stock was bought by a variety of institutional investors in the last quarter, including Advisory Research Inc., Comerica Bank, Columbus Circle Investors, Redwood Investments LLC, Marshall Wace LLP, Nuveen Asset Management LLC, Principal Financial Group Inc., and Principal Financial Group Inc..
View insider buying and selling activity for Addus Homecare

How do I buy shares of Addus Homecare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Addus Homecare's stock price today?

One share of ADUS stock can currently be purchased for approximately $96.33.

How big of a company is Addus Homecare?

Addus Homecare has a market capitalization of $1.51 billion and generates $648.79 million in revenue each year. Addus Homecare employs 33,238 workers across the globe.

What is Addus Homecare's official website?

The official website for Addus Homecare is www.addus.com.

How can I contact Addus Homecare?

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.